Both in Biotechnology
Attovia Therapeutics vs Entera Bio
Over the past year ATTO returned −33.3% and ENTX returned +12.7%; their daily moves had a correlation of 0.14.
ATTO −33.3% ENTX +12.7%Growth of $1, one year, split-adjusted
| Metric | ATTO | ENTX |
|---|---|---|
| Price | $15.19 | $3.20 |
| Market cap | $693.4M | $556.6M |
| Today | −0.52% | +2.56% |
| 1 month | −14.6% | +10.7% |
| 6 months | — | +190.9% |
| Year to date | — | +64.9% |
| 1 year | — | +17.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $11.0M |
| Dividend yield | — | — |
| Volatility (60d) | — | 61.9% |
| Short % of float | 5.6% | 3.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).